13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q1 2019. See the latest, Q2 2026 →
Reported value
$489.55B
+13% on the quarter before
Positions
5,798
610 new · 606 sold out
Top 10
15.6%
of the value
Est. gain
+$48.69B
on stocks held all quarter
Est. return
+13.4%
on those stocks since Q4 2018
Positions as of Mar 31, 2019, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 25% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2018. Striped tiles are options.
Largest buys
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Vanguard Charlotte Fds~$2.34BAdded · 0.3% → 0.8%+41,894,693 shares
- Ishares Tr~$1.65BAdded · 0.5% → 0.8%+19,561,293 shares
- Ishares Tr~$1.58BAdded · 0.0% → 0.4%+14,831,635 shares
- Ishares Tr~$1.30BAdded · 0.0% → 0.3%+12,237,446 shares
- SPDR S&P 500 ETF Tr~$1.18BAdded · 4.8% → 5.1%+4,184,377 shares
- ApplePUT~$1.11BAdded · 0.0% → 0.3%+5,828,500 underlying
- Invesco Qqq TrPUT~$999.0MAdded · 0.2% → 0.4%+5,560,300 underlying
- TSMC~$930.2MAdded · 0.4% → 0.6%+22,710,705 shares
- Ishares Tr~$773.4MAdded · 0.0% → 0.2%+6,496,225 shares
- Ishares IncCALL~$673.5MAdded · 0.1% → 0.2%+16,430,400 underlying
Largest sells
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$775.7MCut · 1.4% → 1.3%−4,083,522 shares
- Johnson & Johnson~$698.1MCut · 0.7% → 0.5%−4,994,207 shares
- Mondelez Intl Inc~$645.6MCut · 0.4% → 0.3%−12,931,975 shares
- Cvs Health Corp~$590.9MCut · 0.3% → 0.1%−10,957,124 shares
- Unitedhealth Group Inc~$555.0MCut · 1.0% → 0.8%−2,244,717 shares
- Ishares TrCALL~$524.8MCut · 0.2% → 0.2%−3,857,600 underlying
- Adobe~$512.2MCut · 0.2% → 0.1%−1,922,147 shares
- Electronic Arts IncCALL~$488.8MCut · 0.1% → 0.0%−4,809,400 underlying
- Pepsico Inc~$453.7MCut · 0.4% → 0.3%−3,701,968 shares
- Ishares Inc~$453.4MCut · 0.5% → 0.3%−8,285,914 shares
Holdings
As of Mar 31, 2019. Changes are in shares against Dec 31, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrFUND · shares +5.0% · price +13.0% | 5.1% | $24.78B | +$2.72B | ||||||||
| MicrosoftCOMMON · shares +3.5% · price +16.1% | 2.2% | $10.81B | +$1.45B | ||||||||
| AmazonCOMMON · shares +1.6% · price +18.6% | 1.5% | $7.54B | +$1.16B | ||||||||
| AppleCOMMON · shares −11% · price +20.4% | 1.3% | $6.38B | +$1.08B | ||||||||
| Ishares TrFUND · shares −5.8% · price +10.3% | 1.2% | $5.82B | +$545.5M | ||||||||
| AlphabetCOMMON · shares +1.0% · price +13.3% | 0.93% | $4.55B | +$528.4M | ||||||||
| Pfizer IncCOMMON · shares −4.6% · price −2.7% | 0.91% | $4.43B | −$123.2M | ||||||||
| Merck & Co IncCOMMON · shares +17% · price +8.8% | 0.88% | $4.31B | +$299.0M | ||||||||
| Bank Amer CorpCOMMON · shares −8.7% · price +12.0% | 0.81% | $3.99B | +$426.2M | ||||||||
| Ishares TrFUND · shares +72% · price +0.6% | 0.80% | $3.93B | +$13.6M | ||||||||
| Vanguard Charlotte FdsFUND · shares +151% · price +2.8% | 0.79% | $3.89B | +$42.3M | ||||||||
| Unitedhealth Group IncCOMMON · shares −13% · price −0.7% | 0.78% | $3.80B | −$28.6M | ||||||||
| AlphabetCOMMON · shares −2.6% · price +12.6% | 0.76% | $3.70B | +$414.9M | ||||||||
| AlibabaADR · shares +4.8% · price +33.1% | 0.74% | $3.61B | +$856.1M | ||||||||
| SPDR S&P 500 ETF TrPUTOPTION · shares +4.4% | 0.73% | $3.55B | — | ||||||||
| Texas InstrumentsCOMMON · shares −0.7% · price +12.2% | 0.64% | $3.15B | +$343.4M | ||||||||
| Jp Morgan Exchange Traded FdFUND · shares −5.5% · price +7.6% | 0.64% | $3.11B | +$218.9M | ||||||||
| TSMCADR · shares +44% · price +11.0% | 0.63% | $3.07B | +$211.4M | ||||||||
| Jp Morgan Exchange Traded FdFUND · shares +2.4% · price +10.4% | 0.61% | $3.00B | +$276.1M | ||||||||
| Visa Inc.COMMON · shares +0.8% · price +18.4% | 0.60% | $2.93B | +$451.1M | ||||||||
| Home Depot IncCOMMON · shares −2.2% · price +11.7% | 0.60% | $2.92B | +$305.6M | ||||||||
| MastercardCOMMON · shares −7.3% · price +24.8% | 0.60% | $2.92B | +$580.1M | ||||||||
| Coca Cola CoCOMMON · shares +18% · price −1.0% | 0.58% | $2.85B | −$25.3M | ||||||||
| Ishares TrFUND · shares −1.2% · price +10.5% | 0.57% | $2.79B | +$265.1M | ||||||||
| Ishares TrFUND · shares −0.5% · price +13.1% | 0.56% | $2.74B | +$317.7M | ||||||||
| Total · 5,798 positions | 100% | $489.55B | +$48.69B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2018 to Q1 2019: 4,346 stocks held throughout, up $48.69B (+13.4%).
- SPDR S&P 500 ETF Tr+$2.72B+13%
- Microsoft+$1.45B+16%
- Amazon+$1.16B+19%
- Apple+$1.08B+20%
- Alibaba+$856.1M+33%
- Biogen Inc−$115.4M−21%
- Pfizer Inc−$123.2M−3%
- Cme Group Inc−$143.9M−13%
- Centene Corp Del−$194.2M−54%
- Cigna Corp New−$261.8M−15%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 22 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |